HRP20030154B1 - Preparation of risperidone - Google Patents

Preparation of risperidone

Info

Publication number
HRP20030154B1
HRP20030154B1 HR20030154A HRP20030154A HRP20030154B1 HR P20030154 B1 HRP20030154 B1 HR P20030154B1 HR 20030154 A HR20030154 A HR 20030154A HR P20030154 A HRP20030154 A HR P20030154A HR P20030154 B1 HRP20030154 B1 HR P20030154B1
Authority
HR
Croatia
Prior art keywords
risperidone
preparation
theta
degrees
ray diffraction
Prior art date
Application number
HR20030154A
Other languages
English (en)
Croatian (hr)
Inventor
Diller Dov
Krochmal Barnaba
Dolitzky Ben-Zion
Aronhime Judith
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26919535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030154(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of HRP20030154A2 publication Critical patent/HRP20030154A2/xx
Publication of HRP20030154B1 publication Critical patent/HRP20030154B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20030154A 2000-08-14 2001-08-14 Preparation of risperidone HRP20030154B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22536100P 2000-08-14 2000-08-14
US24326300P 2000-10-25 2000-10-25
PCT/US2001/025387 WO2002014286A1 (en) 2000-08-14 2001-08-14 Preparation of risperidone

Publications (2)

Publication Number Publication Date
HRP20030154A2 HRP20030154A2 (en) 2005-04-30
HRP20030154B1 true HRP20030154B1 (en) 2009-03-31

Family

ID=26919535

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030154A HRP20030154B1 (en) 2000-08-14 2001-08-14 Preparation of risperidone

Country Status (20)

Country Link
US (2) US6750341B2 (enExample)
EP (2) EP1982980A1 (enExample)
JP (3) JP3751942B2 (enExample)
KR (2) KR100818875B1 (enExample)
AT (1) ATE401313T1 (enExample)
AU (1) AU2001284880A1 (enExample)
CA (1) CA2419314C (enExample)
CZ (1) CZ2003668A3 (enExample)
DE (1) DE60134899D1 (enExample)
ES (1) ES2310410T3 (enExample)
HR (1) HRP20030154B1 (enExample)
HU (1) HUP0302874A2 (enExample)
IL (2) IL154417A0 (enExample)
IS (1) IS6713A (enExample)
MX (1) MXPA03001337A (enExample)
NZ (1) NZ524554A (enExample)
PL (1) PL365608A1 (enExample)
PT (1) PT1783118E (enExample)
SK (1) SK2982003A3 (enExample)
WO (1) WO2002014286A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
WO2004020439A2 (en) * 2002-08-30 2004-03-11 Sunil Sadanand Nadkarni Improved process for preparation of risperidone
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
CN100390146C (zh) 2002-11-13 2008-05-28 斯索恩有限公司 制备利培酮的方法和用于该方法的中间体
US20040180935A1 (en) * 2003-02-28 2004-09-16 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. Crystalline form Z of rabeprazole sodium and process for preparation thereof
AU2003245028A1 (en) * 2003-04-16 2004-11-04 Hetero Drugs Limited A novel crystalline form of risperidone
ES2331001T3 (es) 2003-10-16 2009-12-18 Symed Labs Limited Forma cristalina de linezolid.
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
EP2633853A1 (en) * 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Long-term delivery formulations and methods of use thereof
DE602004009344T2 (de) * 2004-04-19 2008-07-10 Symed Labs Ltd., Hyderabad Neues verfahren zur herstellung von linezolid und verwandten verbindungen
HUP0401379A3 (en) * 2004-07-08 2006-04-28 Richter Gedeon Vegyeszet Process for the preparation of risperidon
US20080262445A1 (en) * 2004-09-08 2008-10-23 Dermatrends, Inc. Transdermal Delivery of Hydrophobic Bioactive Agents
HUP0402163A2 (en) * 2004-10-25 2006-05-29 Richter Gedeon Vegyeszet Process for the preparation of risperidone
CA2607524A1 (en) * 2005-04-27 2006-11-09 Umn Pharma Inc. Agent for prophylaxis and treating of pancreatitis
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007093870A2 (en) * 2006-02-15 2007-08-23 Orchid Chemicals & Pharmaceuticals Limited A process for the preparation of risperidone
US7820816B2 (en) * 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
BRPI0811319A2 (pt) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
DK3006024T3 (da) 2009-01-20 2019-06-03 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Benzoesyre eller salte deraf til forstærkning af aktiviteten af et neurofarmaceutisk lægemiddel
CN102786521B (zh) * 2011-05-18 2016-01-13 中国医学科学院药物研究所 利培酮晶iii型物质及制备方法与在药品和保健品中应用
CN105367570B (zh) * 2015-12-08 2017-10-10 天津市亨必达化学合成物有限公司 一种利培酮晶i型物质的制备方法
CA3027300C (en) 2016-06-13 2023-08-08 Syneurx International (Taiwan) Corp. Co-crystals of lithium benzoate and uses thereof
DK3468944T3 (da) 2016-06-13 2023-02-06 Syneurx Int Taiwan Corp Co-krystaller af natriumbenzoat og anvendelser deraf

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
ES2050069B1 (es) 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
ES2074966B1 (es) 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
CA2242761A1 (en) * 1996-01-26 1997-07-31 William W. Freimuth Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
CZ295402B6 (cs) 2000-05-05 2005-08-17 Rpg Life Sciences Limited Způsob přípravy antipsychotického 3-[2-[4-(6-fluor-1,2-benzizoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-onu
US20020115672A1 (en) * 2000-08-08 2002-08-22 Barnaba Krochmal Preparation of risperidone
US20020193386A1 (en) 2002-03-28 2002-12-19 Inigo Pfeiffer Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives

Also Published As

Publication number Publication date
KR100818875B1 (ko) 2008-04-01
ES2310410T3 (es) 2009-01-01
EP1317434A1 (en) 2003-06-11
CA2419314C (en) 2006-07-11
HRP20030154A2 (en) 2005-04-30
JP2008056699A (ja) 2008-03-13
PT1783118E (pt) 2008-08-19
NZ524554A (en) 2005-07-29
PL365608A1 (en) 2005-01-10
US20020115673A1 (en) 2002-08-22
EP1317434A4 (en) 2005-06-22
SK2982003A3 (en) 2004-10-05
US7256195B2 (en) 2007-08-14
US6750341B2 (en) 2004-06-15
KR20030022389A (ko) 2003-03-15
WO2002014286A9 (en) 2003-03-27
JP2006028192A (ja) 2006-02-02
JP2004506622A (ja) 2004-03-04
IS6713A (is) 2003-02-11
HUP0302874A2 (hu) 2003-12-29
JP3751942B2 (ja) 2006-03-08
AU2001284880A1 (en) 2002-02-25
EP1982980A1 (en) 2008-10-22
WO2002014286A1 (en) 2002-02-21
DE60134899D1 (de) 2008-08-28
KR20080028513A (ko) 2008-03-31
CZ2003668A3 (en) 2004-04-14
IL154417A0 (en) 2003-09-17
ATE401313T1 (de) 2008-08-15
CA2419314A1 (en) 2002-02-21
IL154417A (en) 2008-11-03
MXPA03001337A (es) 2005-06-30
US20040229905A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
HRP20030154B1 (en) Preparation of risperidone
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
HUP0300268A3 (en) Herbicidal benzoylpyrazole derivatives, compositions containing the same and their use
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
IL144147A0 (en) Regulators of the pct or smoothened pathway, compositions and uses related thereto
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
BG102152A (en) New dolastine derivatives, their preparation and application
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
DE69835773D1 (de) Wasserverträgliche energie-härtbare zusammensetzungen, die maleimidderivate enthalten
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
NO20023400L (no) Nye forbindelser med hypolidemisk og hypokolesteremisk virkning, deres fremstilling samt preparater inneholdendeforbindelsene
PL345561A1 (en) Substituted benzoylcyclohexandiones
AU2001282108A1 (en) Heterocyclically substituted benzoylcyclohexanediones, methods for producing them and their use as herbicides
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
ES2182805T3 (es) Agentes de adhesion modificados con nanoparticulas para agentes de revestimiento y la utilizacion de los mismos.
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
SE9903290D0 (sv) Novel compounds
TR199901017A2 (xx) B�cek ilac� terkibi.
AU5626900A (en) The high bone mass gene of 11q13.3
PL371365A1 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.
ZA200205260B (en) Compositions for the manufacture of organo-mineral products, products obtained therefrom and their use.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090325

Year of fee payment: 2

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20090815